The development and growth of the rat heart implies hyperplasia, which stops at birth, and hypertrophy, allowing cardiac mass to grow in response to programmed genetic events along with to haemodynamic overload. Moreover, hypertrophy is accomplished to apoptosis which controls the final number of myocardial cells, deletes vestigial structures, and takes part in remodelling the organ. Since at the basis of all these processes, which lead to the complete development of the heart, the activation of specific signalling pathways underlies, attention has been addressed to the role played in vivo by Protein Kinase C~(PKCO in regulating NF-kB signalling system and "intrinsic" mitochondrial apoptotic route at days 1,4,10 and 22 of rat life. In fact, a role has been assigned to PKC~in indirectly phosphorylating IKBex, which peaks between 10 and 22 days, through a IKK determining, in turn, NF-kB activation, concomitantly to cytochrome c/ Apaf 1 co-localization in the cytoplasm and caspase-9/caspase-3 activation, which leads to the occurrence of apoptosis. Thus a key role for PKC~in regulating the hypertrophic and apoptotic events leading to establishment of complete function in rat neonatal heart is here suggested.
The progressive development and growth of the heart during the early phase of neonatal life is characterized by structural and functional changes in myocardial cells, involving mitochondria and actin/myosin fibers organization, and in cardiac extracellular matrix concerning organization and increase of connective tissue and blood vessels (1-2).
Hyperplasia, an increase in the number of myocytes, occurs during the prenatal phase of cardiac development and stops after birth, at which time hypertrophy, increase in cell size, becomes the main mechanism by which cardiac mass grows (3) (4) (5) . Cardiac hypertrophy is an adaptive response of the heart to a variety of extrinsic and intrinsic stimuli. It can be considered either a physiological process of cell growth, as it occurs in neonate, or a pathological process which can lead to an affected cardiac function (3) . The hypertrophic response, during which cardiomyocytes increase in size without undergoing cell division, can be due to a programmed genetic event along with a mechanical stretch in response to haemodynamic overload (high pressure) (6) .
In parallel, during development, programmed cell death also occurs deleting vestigial structures, controlling the final number of myocardial cells and the remodelling of the organ (7) (8) . Therefore the whole development of the heart, reached around I month of neonatal life, implies a balance between hypertrophy and apoptosis carried out by activation of specific signalling pathways. In particular, a role has been assigned to Protein kinase C (PKC) E and a in regulating hypertrophic growth of cardiomyocytes (9) (10) and to Protein Kinase C (PKC)~in influencing the expression of cell death regulators Bcl-2 family proteins and/or the express ion of the survi val transcription factor NF-kB (11). Since these molecules have been recognized involved in switching on apoptosis, physiological process which, eliminating redundant cells, leads to a remodelling of myocardium up to adult and aged state, in this study attention has been payed to the role played in vivo by Protein Kinase C (PKC)~in regulating hypertrophic signalling systems mediated by NF-kB and by the "intrinsic" apoptotic route which involves mitochondrial induced pathway at day I, 4, 10 and 22 of rat neonatal heart life. In fact, as elsewhere reported (12, 13) , NF-kB activation is required for hypertrophic growth of cultured cardiomyocytes, while mitochondrial pathway implies the control of cytochrome c release into the cytosol by Bcl-2 family members . The anti-apoptotic Bcl-2 protein resides in the outer mitochondrial wall and inhibits cytochrome c release. The pro-apoptotic Bad, Bid, Bax and Bil11 molecules reside in the cytosol but, following the death signalling, they trans locate to the mitochondria where they promote cytochrome c release. Bad trans locates to mitochondria and forms a pro-apoptotic complex with Bel-xl. Released cytochrome c binds Apaf-I (apoptotic activating factor I) and forms acomplex with key initiator caspase 9, which, sequentially, activates the execution factor caspase-3 (14, (17) (18) (19) . Finally, our aim has been to define in vivo the threshold age when development is accomplished and growth gets starting, paying attention to the related molecular mechanisms leading to the establishment of the complete function of rat neonatal heart.
MATERIALS AND METHODS

Animals
Four groups, each composed of 10 Wistar rats I, 4, 10 and 22 days old, were processed according to protocols approved by the local Bioethical Animal Care Committee. Only animals free of acute and chronic illness were employed and kept under physiological conditions. Rats were anaesthesized with Nembutal (40 mg/Kg) and dissected. Left ventricles were excised from each rat and processed for experiments.
TUNEL method
TUNEL (terminaldeoxinucleotidyl transferasemediated dUTP nick end-labeling) is a method of choice for a rapid identification and quantification of apoptotic cells. DNA strand breaks, yielded during apoptosis, can be identified by labeling free 3'-OH termini with modified nucleotides in an enzymatic reaction. Paraffin embedded tissue sections dewaxed, rehydrated and preincubated with Proteinase K 20 f-Lg/ ml in 10 mrnol/L Tris-HCl pH 7.6 were exposed to TUNEL mixture, according to illustration sheet (Boheringer Mannheim, Germany). After two rinses in PBS, slides were mounted by using a propidium iodideglycerol solution (10 u.g/rnl) and analyzed under fluorescent microscope (Le i c a Cambridge Ltd.,Cambridge, U.K.). Negative control was performed by omitting the incubation in the presence of the enzymatic mixture.
Immunch istoc hem i sfry
Heart samples were processed according to literature and sections haernatoxylin-eosin routinely stained (20) . To detect Phospho-Ikb-« and Bax proteins, slides, blocked in PBS, 5% NGS, 0.1 % bovine serum album ine, 0.1 % Tween-20, were firstly incubated in the presence of mouse Bax and p-IkB-O' monoclonal antibodies (Santa Cruz Lab., Santa Cruz, CA, USA) and then in the presence of biotinylated secondary antibodies and StreptAvidin-peroxidase conjugated. Peroxidase was developed by using diaminobenzidine chromogen (DAB) (BIOMEDA Corp., Ca, USA) and nuclei were hematoxylin counterstained, following the manufactory suggestions. Negative control was performed by omitting the primary antibody (not shown).
Immunoelectronmicroscopy
Heart samples were routinely processed for morphological ultrastructural study (21) . Other samples were fixed in 4% paraformaldehyde, 0.1 % glutaraldehyde, 0.1 mol/L cacodylate buffer, pH 7.6, for 3 hr at4°C and then processed for immunolocalization, according to literature (20) . To block non-specific binding sites, grids were blocked in PBS 0.1 % Tween, 0.1 % BSA, 3 % normal goat serum (NGS), incubated in the presence of mouse cytochrome c monoclonal antibody (Santa Cruz Lab., Santa Cruz, CA, USA) and then in the presence of a secondary anti body conjugated with 15nm colloidal gold particles (Biocell, Cardiff, U.K.). Uranyl acetate and lead citrate counterstained grids were observed by using a Zeiss electron microscope 109.
Immunoprecipitation
Total cellular Iysates (500 u.g as protein) were supplemented with 2 u.g of mouse cytochrome c or PKC~monoclonal antibody for I hour at 4°C and incubated with 20 u.l of Protein G-Agarose at 4°C on a rocker platform for I hour. Immunoprecipitated proteins were collected by centrifugation at 2500 rpm, washed 4 times in RIPA buffer. After final wash, pellets were resuspended in sample buffer 2x.
Western blotting analysis
Total cell lysates or immunoprecipitated proteins were electrophoresed and transferred to nitrocellulose, as previously descri bed (21) . Nitrocelluloses, blocked in 5% non-fat milk, 10 mmol/L Tris pH 7.5, 100 mmol/ L NaCI, 0.1 % Tween-20, were probed with goat Bad or rabbit Apaf-I, lAP (Inhibiting apoptosis protein) or PKC Spolyclonal antibodies or mouse Bax,Bcl-2, NF-kB, p-IkBa, cytochrome c, caspase-9, caspase-3 monoclonal antibodies (Santa Cruz Lab., Santa Cruz, CA, USA) and then incubated in the presence of enzyme conjugated anti-goat, anti-rabbit or anti-mouse IgG horseradish peroxidase. Immunoreactive bands were detected by ECL detection system (Amersham IntI., Buckinghamshire, U.K.) and analyzed by densitometry. Blots were simultaneously incubated in the presence of mouse ex sarcomeric actin monoclonal antibody to show that each electrophoretic lane was loaded with equal amount of myocardial proteins.
In vitro PKC Sactivity assay Immunoprecipitated PKC Swas incubated at 30°C for 10 min in 20 mmol/LTris-HCI, pH 7.4,10 mmol/L MgCI 2 , 10 p.mol/L ATP, 5 fLCi [g 3 2 P] ATP, 1.2 mmol/ L CaCI 2 , 40 u.g/ml phosphatidyl serine (PS), 10 u.g of the appropriate synthetic peptide QKRPSQRSKYL, corresponding to sequence derived from myelin basic protein (MBP) (Santa Cruz Lab., Santa Cruz, CA, USA). Proteins, resuspended in 2x sample buffer, were separated by using a 18% SDS-PAGE. Gels were then dried and exposed to X-ray films for 16 hr at -80°C. Peptide spots were excised and radioactivity was measured in a liquid scintillation counter.
Image processing and analysis system Quantitative analysis was performed by using a Sony videocamera connected to a Lcica Quantimet 500 plus software (Leica Cambridge Ltd., Cambridge, U.K.) determining the change in Integrated Optical Intensity (1.0.1.) using ISO transmission density Kodak CAT 152-3406 (Eastman Kodak Company, Rochester, USA) as standard.
Results were expressed as mean ± SD. Statistical analysis was performed using the analysis of variance (ANaYA). Probability of null hypothesis of <0.1 % (p<0.05) was considered statistically significant.
RESULTS
At birth mammalian myocardium discloses a substantial number of myocardiocytes, due to prenatal hyperplasia. These cells undergo postnatal hypertrophic growth, enlarging in size to achieve the final cardiac mass. During early postnatal period the connective compartment, on turn, is scarcely represented (22) (23) (24) (25) .
As expected fig. I shows, therefore, in rat myocardial tissue,this kind of response probably due to a programmed genetic event along with a mechanical stretch induced by haemodynamic overload. In fact, at day I cells are small, with round nuclei and surrounded by abundant blood vessels. During the following days the progressive structural fiber organization along with an enlargement of cells and nuclei and an increased amount of connective interstitial tissue can be observed. In particular, cells disclosing apoptotic features, like cell membrane shrinkage and chromatin condensation, are evidenced at 22 days (arrow). Also TUNEL analysis, performed on sections previously marked with a sarcomeric actin, to exclude connective cells (not shown), shows a significant increase of apoptotic cell number between 4 and 10 days (Fig.2) , reaching a steady state at 22 days and lowering to basal level in young subjects, as elsewhere reported (20) .
Since both development, cardiac hypertrophy and apoptosis require the involvement of intracellular signal transduction systems to activate transcription factors and so influence and maintain these programs, we have checked the expression and the activation of hypertrophic factor NF-kB and of cell death regulator Bcl-2 family proteins (Bad, Bax and Bcl-2). Even though NF-kB cytochrome c is mainly associated with mitochondria at I day oflife, while at 22 days it is revealed in the ialoplasm (Fig.6) , we have immunoprecipitated cytochrome c from I, 4, 10, 22 day old samples and conjugated it in the presence of Apaf-l monoclonal antibody. Fig.7 shows that Apaf-I coimrnunoprecipitated with cytochrome c in 10 and 22 days samples. In parallel, pro-caspase-9, detected by a mouse monoclonal antibody which recognizes the 37 kD active fragment, is mainly processed and activated by cytocrome c/ Apaf-l complex around 10days of life, determining, in turn, caspase- expression does not modify, its activation is indirectly detected by analysis of regulatory IkBa protein phosphorylative state. In fact, IkBa phosphorylation and degradation in the cytoplasm allows NF-kB translocation to the nucleus. IkBa phosphorylation progressively increases up to 22 days of life, paralleled by a light increase in the expression of lAP, well known caspase inhibitor, occurring between 10and 22 days (Fig.3) . Moreover Bad level increase at 22 days paralleled by Bax decrease and no modification concerning Bcl-2 are evidenced ( Fig.4) . Interestingly, incubation in the presence of Phospho-IkB« and Bax antibodies, performed on serial sections and observed at light microscopy, discloses, in 22 day old rat heart, neighbouring myocardial cells expressing differently these two molecules (Fig.f a.b ), which committ their hypertrophic (p-IkBa) or apoptotic fate (Bax) (Fig.S c) . In addition, playing mitochondrial cytochrome c a key role in caspases' activation (26) , attention has been focused on the involvement of such molecule in the occurrence of the apoptotic state during cardiac development.
Since by immunoelectronmicroscopy analysis 3 activation, as revealed by smaller fragments production after 10 and 22 days (Fig.8 ). This evidence supports a possible involvement of the mitochondrial pathway in the occurrence of apoptosis in this experimental model. Lastly, since a role for PKC~has been previously suggested by other and our group (27, II) in activating IkBO' phosphorylation in similar models, attention has been payed to the possible regulation exerted by this protein in our experimental conditions. Fig.9 discloses a decreased expression of PKC~from 10 to 22 days of neonatal life paralleled by a peak of in vitro PKC~activity at 10 days ( Table!) .
DISCUSSION
Haemodynamic loading, probably the most important event for myocyte growth and stretching, occurs early and involves both hypertrophy and apoptosis during rat heart development (28) . Cardiac hypertrophy is a positive and, at the same time, negative adaptive response of the cells to biochemical stress exerted by pressure overload. In fact, a hypertrophy of compensatory nature occurs at birth, while at adult state a widespread hypertrophy can often undergo a transition to heart failure, a leading cause of mortality In industrialized countries (29) .
Both developmental and pathological hypertrophy of the myocardium require apoptosis which, leading to myocyte loss, is thought to contribute to reach the whole development of the heart or its failure, respectively. Moreover the question is how these processes are initiated and regulated and which are the underlying molecular mechanisms. To understand better the balance between hypertrophy and apoptosis, which seems to regulate development, we report here some of the molecular mechanisms mediating the establishment of this balance in rat heart at different ages of neonatal life. Starting from the Ist day of life, we have investigated the 4 th day to evaluate molecular and morphological modifications following the early adaptation of postnatal life. As previously described (II), 10 days of life was chosen as the crucial time useful to achieve the differentiation state involving apoptosis, while 22 days represent a late stage of neonatal life. Morphological modifications evidenced during development are sustained by hypertrophic factor NF-kB activation, which peaks at 22 days, concomitantly with an unexpected increase of lAP and Bad expression from 10 to 22 days, while Bax amount decreases.
Since PKC cannot directly phosphorylate IkBa, it could be argued that the signals generated by PKC~activation could be mediated by the novel IkB kinase (lKK), as already reported in other experimental models (30) (31) (32) . IKB kinase complex is formed by two catalytic subunits (Ikk« and Ikkjs) and one regulatory subunit (Ikkv). In our experimental model PKC~could phosphorylate Ikko on serine 176 and 180 or Ikkb on serine 177 and 181 which are the specific sites whose phosphorylation causes a conformational change that results in kinase activation. Ikks phosphorylated can activate IkBcc, inhibitory protein, which, inducing NF-kB translocation, delivers an hypertrophic signal. In parallel, close to hypertrophy committed myocytes, 22 day old rat neonatal heart discloses apoptosis committed cells, as evidenced by immunohistochemical analysis of both p-Ikb« and Bax expression, performed on paraffin embedded serial sections. In addition, Bad increase, not allowing Bcl2/Bax heterodimerization, promotes Bax homodimerization and induces the occurrence of apoptosis (20) . However, the complex cytochrome c/ Apaf-I processing caspase-9/ caspase-3 between 10 and 22 days of neonatal life suggests the involvement of the "intrinsic" apoptotic route in the occurrence of apoptosis in this experimental model. Thus, caspase-3, key molecule regulating the occurrence of apoptosis, could be activated by cytochrome c/Apaf-I /caspase-9 complex and inactivated by NF-kB stimulated lAP protein, allowing cross-talk between the two metabolic pathways. However, as the young state is reached, both these processes weaken until old age, when they are switched on again (20) .
Thus we can suggest PKC~as key molecule in the regulation of the hypertrophic and apoptotic events, following also genetic programs, involved in the occurrence of growth, development and remodelling of rat heart, aimed to reach and maintain the complete function of the organ.
